SCHEMBL234747

SCHEMBL234747

[C]1C=CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517038 0.58
SCHEMBL1762395 0.58
SCHEMBL59324 0.58
SCHEMBL6518271 0.58
SCHEMBL9053351 0.55
Water SCHEMBL8371446 0.55
SCHEMBL19341 0.54
SCHEMBL155148 0.54
SCHEMBL129122 0.53
SCHEMBL27572 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540370-B2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors ABBVIE DEUTSCHLAND GMBH & CO., KG. (DE) 2017-01-10 US claimed
US-20150274724-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS AbbVie Deutschland GmbH & Co. KG (DE) 2015-10-01 US claimed
US-9090592-B2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors AbbVie Deutschland GmbH & Co. KG (DE) 2015-07-28 US claimed
EP-2658854-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS Abbvie Deutschland GmbH & Co. KG (DE) 2013-11-06 EP claimed
WO-2012089828-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS ABBOTT GMBH & CO. KG (DE) 2012-07-05 WO claimed
US-20120172376-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS ABBOTT GMBH & CO. KG (DE) 2012-07-05 US claimed
US-20240238460-A1 IMPROVED PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETING RADIOPHARMACEUTICALS AND USES THEREOF TELIX PHARMACEUTICALS INNOVATIONS PTY LTD (AU) 2024-07-18 US disclosed
EP-4396163-A1 HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS BASF SE (DE) 2024-07-10 EP disclosed
EP-4396173-A1 HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM BASF SE (DE) 2024-07-10 EP disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
EP-4392403-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2024-07-03 EP disclosed
EP-4392414-A1 INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2024-07-03 EP disclosed
EP-4391808-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2024-07-03 EP disclosed
EP-0456090-A2 Herbicidal agents containing cyclohexenone derivatives as active ingredients and naphthalene derivatives as antidotes BASF Aktiengesellschaft (DE) 1991-11-13 EP disclosed
EP-0456069-A1 Cyclohexenonoximethers, process and intermediates for their production and their usage as herbicides BASF Aktiengesellschaft (DE) 1991-11-13 EP disclosed
EP-0456068-A1 Cyclohexenonoximethers, process and intermediates for their production and their use as herbicides BASF Aktiengesellschaft (DE) 1991-11-13 EP disclosed
US-5022914-A Pre- and post-emergence; broad leaf plants; rice BASF AKTIENGESELLSCHAFT (DE) 1991-06-11 US disclosed
EP-0400356-A1 Sulfonamides BASF Aktiengesellschaft (DE) 1990-12-05 EP disclosed
EP-0368227-A1 Cyclohexenone oxime ethers, process for their preparation and their use as herbicides BASF Aktiengesellschaft (DE) 1990-05-16 EP disclosed
US-4618362-A USING CYCLOHEXAN-1,3-DIONE DERIVATIVE BASF AKTIENGESELLSCHAFT (DE) 1986-10-21 US disclosed